Yesid Alvarado

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia & lymphoma

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Hagop M Kantarjian, Nicholas James Short, Fady Gh Haddad, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamana, Tapan Mahendra Kadia, Naval G Daver, Kelly Sharon Chien, Yesid Alvarado, Guillermo Garcia Manero, Ghayas C Issa, Rebecca Garris, Cedric Nasnas, Lewis Fady Nasr, Farhad Ravandi, Elias J Jabbour
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Alexandre Bazinet, Tapan M Kadia, Nicholas James Short, Gautam Borthakur, Sa A Wang, Wei Wang, Sanam Loghavi, Jeffrey L Jorgensen, Keyur Pravinchandra Patel, Courtney D D DiNardo, Naval G Daver, Yesid Alvarado, Fadi G Haddad, Sherry R Pierce, Graciela Nogueras Gonzalez, Abhishek Maiti, Koiji Sasaki, Musa Ylimaz, Phillip A Thompson, William G Wierda, Guillermo Garcia-Manero, Michael Andreeff, Elias J Jabbour, Marina Y Konopleva, Xuelin Huang, Hagop M Kantarjian, Farhad Ravandi
Undetectable Measurable Residual Disease is Associated with Improved Outcomes in AML Irrespective of Treatment Intensity. Blood advances (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D D DiNardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Elias J Jabbour, Fadi G Haddad, Nicholas James Short, Jayastu Senapati, Nitin Jain, Koiji Sasaki, Jeffrey L Jorgensen, Sa A Wang, Yesid Alvarado, Xuemei Wang, Courtney D D DiNardo, Lucia Masarova, Tapan M Kadia, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Inotuzumab Ozogamicin for Measurable Residual Disease in Acute Lymphoblastic Leukemia in Remission. Blood (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D D DiNardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D D DiNardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Courtney D D DiNardo, Sangeetha Venugopal, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Guillermo Montalban-Bravo, Xuemei Wang, Hetty E Carraway, Mikkael A Sekeres, Ameenah Sukkur, Danielle Hammond, Kelly Sharon Chien, Abhishek Maiti, Lucia Masarova, Koiji Sasaki, Yesid Alvarado, Tapan M Kadia, Nicholas James Short, Naval G Daver, Gautam Borthakur, Farhad Ravandi, Hagop M Kantarjian, Bhumika J Patel, Amy E DeZern, Gail J Roboz, Guillermo Garcia-Manero
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome. Blood advances (2022)
Courtney D D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan Mahendra Kadia, Naval G Daver, Maria Adeoti, Nicholas James Short, Koiji Sasaki, Sa Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Elias J Jabbour, Guillermo Garcia Manero, Steven Mitchell Kornblau, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (25) (2021)